Impact of a Single Art Therapy Session on Mood and Symptom Burden in Palliative Care (NCT06924268) | Clinical Trial Compass
By InvitationNot Applicable
Impact of a Single Art Therapy Session on Mood and Symptom Burden in Palliative Care
Canada20 participantsStarted 2025-06-01
Plain-language summary
The goal of this observational study is to explore whether a single art therapy session can improve mood and reduce symptom burden in adult palliative care patients at a Canadian inpatient unit. The main questions it aims to answer are:
* Does a single art therapy session reduce overall symptom burden, as measured by the Edmonton Symptom Assessment System (ESAS)?
* Does a single art therapy session improve mood, as measured by the Positive and Negative Affect Schedule (PANAS)?
Participants will:
* Complete two short questionnaires (ESAS and PANAS) before and after the session
* Participate in a 30-60 minute individual art therapy session
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* inclusion if they are adults (=18 years old)
* admitted to the PCU
* have the ability to communicate
* complete self-assessments with or without facilitator assistance
* possess the ability to engage in a 30-60 minute art therapy session
Exclusion Criteria:
* Patients will be excluded if they are under 18 years of age
* within 48hrs of admission or discharge
* experiencing severe cognitive impairment, uncontrolled symptoms, or delirium.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Positive and Negative Affect Scores Measured by PANAS Before and After Art Therapy
Timeframe: Immediately before and immediately after the art therapy session
2
Change in Symptom Burden Measured by Modified ESAS Before and After Art Therapy
Timeframe: Immediately before and immediately after the art therapy session